GlycoMimetics
Why Robinhood?
You can watch GlycoMimetics and buy or sell other stocks, ETFs, and their options commission-free!About GLYC
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
GLYC Key Statistics
Stock Snapshot
With a market cap of 359.34M, GlycoMimetics(GLYC) trades at $13.04. The stock has a price-to-earnings ratio of -1.08.
During the trading day, GlycoMimetics(GLYC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 263.98K.
The stock's 52-week range extends from a low of $8.72 to a high of $28.77.
The stock's 52-week range extends from a low of $8.72 to a high of $28.77.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.